Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers

Journal of Immunology

Volumn 164, Issue 1, 2000, Pages 208-216

  Slifka, Mark K ^a   Whitton, J Lindsay ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOSTIMULATION; INTERFERON PRODUCTION; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 0033961476     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.1.208     Document Type: Article

References (63)

1. Webster, A. D. 1994. Virus infections in primary immunodeficiency. J. Clin. Pathol. 47:965.
2. Klavinskis, L. S., M. B. A. Oldstone, and J. L. Whitton. 1989. Designing vaccines to induce cytotoxic T lymphocytes: protection from lethal viral infection. In Vaccines 89: Modern Approaches to New Vaccines Including Prevention of AIDS. F. Brown, R. Chanock, H. Ginsberg, and R. Lerner, eds. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, p. 485.
3. Whitton, J. L., and M. B. A. Oldstone. 1996. The immune response to viruses. In Fields' Virology, 3rd Ed. B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Raven Press, New York, p. 345.
4. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
5. + T cells during an acute virus infection. Immunity 8:167.
6. Zarozinski, C. C., and R. M. Welsh. 1997. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J. Exp. Med. 185: 1629.
7. Green, D. R., and D. W. Scott. 1994. Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6:476.
8. Russell, J. H. 1995. Activation-induced death of mature T cells in the regulation of immune responses. Curr. Opin. Immunol. 7:382.
9. Lau, L. L., B. D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648.
10. Demkowicz, W. E. J., R. A. Littaua, J. Wang, and F. A. Ennis. 1996. Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol. 70: 2627.
11. + T cells. Scand. J. Immunol. 42:110.
12. + cytotoxic T cell activation and memory in virus infection. J. Immunol. 149:1326.
13. Budd, R. C., J. C. Cerottini, C. Horvath, C. Bron, T. Pedrazzini, R. C. Howe, and H. R. Macdonald. 1987. Distinction of virgin and memory T lymphocytes: stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J. Immunol. 138:3120.
14. + memory T cells. J. Immunol. 154:5870.
15. + T cells from naive cells. J. Immunol. 161:641.
16. Sprent, J. 1994. T and B memory cells. Cell 76:315.
17. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54.
18. Dutton, R. W., S. L. Swain, and L. M. Bradley. 1999. The generation and maintenance of memory T and B cells. Immunol. Today 20:291.
19. Zinkernagel, R. M., and P. C. Doherty. 1979. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv. Immunol. 27:51.
20. Oldstone, M. B. A., R. Ahmed, J. Byrne, M. J. Buchmeier, Y. Riviere, and P. Southern. 1985. Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis. Br. Med. Bull. 41:70.
21. Whitton, J. L. 1990. Lymphocytic choriomeningitis virus CTL. Semin. Virol. 1:257.
22. Campbell, I. L., M. V. Hobbs, P. Kemper, and M. B. A. Oldstone. 1994. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J. Immunol. 152:716.
23. + T cell interactions in IFN-γ and IL-4 responses to viral infections: requirements for IL-2. J. Immunol. 160:5007.
24. + T cells during acute infection with lymphocytic choriomeningitis virus. J. Immunol. 161:3215.
25. Whitmire, J. K., M. S. Asano, K. Murali-Krishna, M. Suresh, and R. Ahmed. 1998. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J. Virol. 72:8281.
26. + T cells. Nature 401:76.
27. Ahmed, R., A. Salmi, L. D. Butler, J. M. Chiller, and M. B. A. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice: role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521.
28. Byrne, J. A., and M. B. A. Oldslone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682.
29. + T lymphocytes mediate clearance of virus and regulate the antiviral Ab response. J. Virol. 61:1867.
30. Fung-Leung, W. P., T. M. Kundig, R. M. Zinkernagel, and T. W. Mak. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425.
31. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
32. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA 91:10854.
33. Whitton, J. L., A. Tishon, H. Lewicki, J. R. Gebhard, T. Cook, M. S. Salvato, E. Joly, and M. B. A. Oldstone. 1989. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J. Virol. 63:4303.
34. Sourdive, D. J., K. Murali-Krishna, J. D. Altman, A. J. Zajac, J. K. Whitmire, C. Pannetier, P. Kourilsky, B. Evavold, A. Sette, and R. Ahmed. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J. Exp. Med. 188:71.
35. + T cells in the liver during the control and resolution phases of influenza pneumonia. Proc. Natl. Acad. Sci. USA 95:13812.
36. + memory T cells. J. Exp. Med. 186:859.
37. Slifka, M. K., J. K. Whitmire, and R. Ahmed. 1997. Bone marrow contains virus-specific cytotoxic T lymphocytes. Blood 90:2103.
38. Opferman, J. T., B. T. Ober, and P. G. Ashton-Rickardt. 1999. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283:1745.
39. Cho, B. K., C. Wang, S. Sugawa, H. N. Eisen, and J. Chen. 1999. Functional differences between memory and naive CD8 T cells. Proc. Natl. Acad. Sci. USA 96:2976.
40. Selin, L. K., and R. M. Welsh. 1997. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J. Immunol. 158:5366.
41. Ehl, S., P. Klenerman, P. Aichele, H. Hengartner, and R. M. Zinkernagel. 1997. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur. J. Immunol. 27:3404.
42. Bachmann, M. F., M. Barner, A. Viola, and M. Kopf. 1999. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur. J. Immunol. 29:291.
43. Griffiths, G. M. 1997. Protein sorting and secretion during CTL killing. Semin. Immunol. 9:109.
44. + T cells in primary and secondary influenza pneumonia. Immunity 8:683.
45. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
46. Hayden, F. G., R. Fritz, M. C. Lobo, W. Alvord, W. Strober, and S. E. Straus. 1998. Local and systemic cytokine responses during experimental human influenza A virus infection: relation to symptom formation and host defense. J Clin. Invest. 101:643.
47. Masuda, N., S. Negoro, K. Takeda, N. Kurata, T. Kuwabara, S. Kobayashi, and M. Fukuoka. 1998. Interleukin 6 is a cause of flu-like symptoms in treatment with a deoxycytidine analogue. Br. J Cancer 78:388.
48. Selin, L. K., S. M. Varga, I. C. Wong, and R. M. Welsh. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188:1705.
49. Campbell, I. L. 1995. Neuropathogenic actions of cytokines assessed in transgenie mice. Int. J. Dev. Neurosci. 13:275.
50. Zajac, A. J., J. N. Blattman, K. Murali-Krishna, D. D. Sourdive, M. Suresh, J. D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205.
51. Jacob, J., and D. Baltimore. 1999. Modeling T-cell memory by genetic marking of memory T cells in vivo. Nature 399:593.
52. Pestano, G. A., Y. Zhou, L. A. Trimble, J. Daley, G. F. Weber, and H. Cantor. 1999. Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. Science 284:1187.
53. Linsley, P. S., J. L. Greene, P. Tan, J. Bradshaw, J. A. Ledbetter, C. Anasetti, and N. K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176:1595.
54. Thompson, C. B., and J. P. Allison. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity 7:445.
55. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:2533.
56. Walunas, T. L., C. Y. Bakker, and J. A. Bluestone. 1996. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183:2541.
57. Lee, K. M., E. Chuang, M. Griffin, R. Khattri, D. K. Hong, W. Zhang, D. Straus, L. E. Samelson, C. B. Thompson, and J. A. Bluestone. 1998. Molecular basis of T cell inactivation by CTLA-4. Science 282:2263.
58. Tivol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541.
59. Waterhouse, P., J. M. Penninger, E. Timms, A. Wakeham, A. Shahinian, K. P. Lee, C. B. Thompson, H. Griesser, and T. W. Mak. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985.
60. Waterhouse, P., M. F. Bachmann, J. M. Penninger, P. S. Ohashi, and T. W. Mak. 1997. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 27: 1887.
61. Bachmann, M. F., P. Waterhouse, D. E. Speiser, K. McKall-Faienza, T. W. Mak, and P. S. Ohashi. 1998. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. J. Immunol. 160:95.
62. Liu, Y. 1997. Is CTLA-4 a negative regulator for T-cell activation? Immunol. Today 18:569.
63. Zheng, P., Y. Wu, Y. Guo, C. Lee, and Y. Liu. 1998. B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge. Proc. Natl. Acad. Sci. USA 95:6284.